<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00824447</url>
  </required_header>
  <id_info>
    <org_study_id>AB0602/1</org_study_id>
    <secondary_id>2007-002477-31</secondary_id>
    <nct_id>NCT00824447</nct_id>
  </id_info>
  <brief_title>Long-term Efficacy and Safety Study With Oralgen Grass Pollen</brief_title>
  <official_title>A Randomised, DB, Plcb Controlled, Multicentre, Multinat. Phase II/III FU Study to Assess Longterm Efficacy and Safety of 3 Different Dose Regimens of OralgenÂ® GrassPollen in Patients With Grass Pollen Related Allergic Rhinoconjunctivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Artu Biologicals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Artu Biologicals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to give additional information on the efficacy, safety and local
      effects (tolerability) of a dose of sublingual immunotherapy administered once a day, during
      a second grass pollen season.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Allergy is one of the most common chronic diseases. Allergies to grass, weed, and tree
      pollens characteristically result in seasonal rhinitis symptoms commonly termed hay fever.
      The risk of developing asthma has been noted to be higher in patients with rhinitis than
      among the general population (10% versus 3.6%), confirming the fact that rhinitis is often
      the first step of the natural history of asthma.

      Although several drugs effectively manage the symptoms of allergic rhinitis, conjunctivitis
      or asthma, they do not represent an etiopathogenic treatment of the considered diseases, and
      do not prevent the reappearance of the symptoms at the end of the treatment.

      Immunotherapy is generally considered to be appropriate for patients in whom rhinitis
      symptoms cannot be controlled by an optimal medication regimen and avoidance of the
      allergens. At present, specific immunotherapy is the only therapy available that acts on the
      main cause of the allergic reaction by modifying or down-regulating the immune response.

      Allergen immunotherapy is the administration of gradually increasing quantities of an
      allergen vaccine (extract) to an allergic subject, to reach a maintenance dose, which is
      effective in reducing the symptoms associated with exposure to the causative allergen.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pollen Season Rhinoconjunctivitis Total Symptom Score</measure>
    <time_frame>site specific pollen season</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rescue medication usage</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of symptom-free days during the pollen season</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rhinoconjunctivitis QoL Questionnaire</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global evaluation of the efficacy by the patient</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local and systemic tolerability and other adverse events, labor</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">356</enrollment>
  <condition>Allergic Rhinoconjunctivitis</condition>
  <arm_group>
    <arm_group_label>Placebo control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grass pollen extract, twice weekly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Grass pollen extract, 9,500 BU, given twice weekly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grass pollen extract daily</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Grass pollen extract, 9,500 BU, given daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Increased dose of grass pollen extract</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Increased dose of grass pollen extract, 19,000 BU, given daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oralgen</intervention_name>
    <description>allergen solution sublingually</description>
    <arm_group_label>Grass pollen extract, twice weekly</arm_group_label>
    <arm_group_label>Grass pollen extract daily</arm_group_label>
    <arm_group_label>Increased dose of grass pollen extract</arm_group_label>
    <other_name>grasspollen extract</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo control</description>
    <arm_group_label>Placebo control</arm_group_label>
    <other_name>Placebo control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who meet the in and exclusion criteria for study AB0602 and successfully
             finished this study.

          -  Patients who have given their written consent to participate in this study.

          -  Patients who are willing to comply with the protocol and understand the information
             given.

          -  Female patients of childbearing potential are eligible if they are not sexually active
             or if they use a medically accepted contraceptive method.

          -  Negative urine pregnancy test if female at the end of the previous study.

        Exclusion Criteria:

          -  Pregnancy, breast-feeding / lactation or sexually active women of childbearing
             potential who are not using a medically accepted contraceptive method.

          -  Patients who were non-compliant during study AB0602.

          -  Patients with a past or current disease, which as judged by the investigator, may
             affect the patient's participation in or the outcome of this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>51 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dyonne van Duren, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AMPHA Nijmegen, Toernooiveld 220, 6525EC, Nijmegen, The Netherlands</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Knut Schaekel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitait Klinikum Carl Gustav Carus, Fetscherstrasse 74, SN 01307, Dresden, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Iveta Kozlovska, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum Immunologie a allergologie, Pavla Horova 14, 84108 Bratislava, Slovak Republic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MHAT PLovdiv, ENT Clinic</name>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Medical Academy, Clinic of ENT</name>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Medical Academy</name>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>5th MHAT, ENT Clinic</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ministry of interior-central clinical database</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHAT Sveta Marina</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Medical Academy</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Brno</name>
      <address>
        <city>Brno-Bohunice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ORL Soukroma praxe</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemocnice Caslav</name>
      <address>
        <city>Caslav</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ordinace</name>
      <address>
        <city>Dobruska</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ambulance</name>
      <address>
        <city>Jablonec nad Nisou</city>
        <zip>466 04</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ordinace</name>
      <address>
        <city>Kutna Hora</city>
        <zip>284 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ambulance</name>
      <address>
        <city>Ostrava - Hrabuvka</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulance plicni a alergologicka</name>
      <address>
        <city>Ostrave - Hrabuvka</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ambulance Okresni nemocnice Tabor</name>
      <address>
        <city>Tabor</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsgen. kliniken Bergmannsheil</name>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ. klinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedicoKIT</name>
      <address>
        <city>Goch</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johannes-Gutenberg-Universitat Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vital Care</name>
      <address>
        <city>Muenchen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Privataertz. inst. &amp; Forsh. einrichtung</name>
      <address>
        <city>Wiesbaden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Svabhegyi Allami Gyermekgyogyintezet pulmonologia</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szent Janos Korhaz</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Selye Janos Korhaz</name>
      <address>
        <city>Komarom</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolina Korhaz</name>
      <address>
        <city>Mosomagyarovar</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tudogyogyintezet Torokbalint</name>
      <address>
        <city>Torokbalint</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaunas medical University hospital</name>
      <address>
        <city>Kaunas</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JSC Seimos gydytojas</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilnius Central Outpatient Clinic</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilnius university hospital, Santariskiu Clinic</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ampha Den Bosch / Regio Brabant</name>
      <address>
        <city>'s-Hertogenbosch</city>
        <zip>5233 VG</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ampha De Bilt</name>
      <address>
        <city>De Bilt</city>
        <zip>3731 DN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ampha</name>
      <address>
        <city>Hengelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AMPHA Nijmegen</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525EC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum imunologie a alergologie s.r.o</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amb. klinickey imunologie a allergologie UTaRCH</name>
      <address>
        <city>Poprad</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulancia klinickej imunologie a alergologie</name>
      <address>
        <city>Trencin</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medcentrum s.r.o.</name>
      <address>
        <city>Zilina</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Lithuania</country>
    <country>Netherlands</country>
    <country>Slovakia</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2009</study_first_submitted>
  <study_first_submitted_qc>January 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2009</study_first_posted>
  <last_update_submitted>May 4, 2010</last_update_submitted>
  <last_update_submitted_qc>May 4, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. F.F. Roossien</name_title>
    <organization>Artu Biologicals Europe B.V.</organization>
  </responsible_party>
  <keyword>randomised</keyword>
  <keyword>double-blind</keyword>
  <keyword>placebo-controlled</keyword>
  <keyword>long-term efficacy and safety</keyword>
  <keyword>OralgenÂ® Grass Pollen</keyword>
  <keyword>allergic rhinoconjunctivitis</keyword>
  <keyword>Allergy</keyword>
  <keyword>Rhinoconjunctivitis</keyword>
  <keyword>Immunotherapy</keyword>
  <keyword>Grass pollen extract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

